Ausgabe 3/2013
Inhalt (9 Artikel)
Relative Cardiovascular and Gastrointestinal Safety of Non-selective Non-steroidal Anti-inflammatory Drugs Versus Cyclo-oxygenase-2 Inhibitors
José Pedro Henriques Patrício, Jorge Pinto Pereira Barbosa, Rui Miguel Monteiro Ramos, Nuno Filipe Pimenta Antunes, Pedro Carlos Santos de Melo
Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study
Jin-Kui Yang, Lei Wang
Improved Efficacy of Intramuscular Weekly Administration of Clodronate 200 mg (100 mg Twice Weekly) Compared with 100 mg (Once Weekly) for Increasing Bone Mineral Density in Postmenopausal Osteoporosis
Bruno Frediani, Ilaria Bertoldi, Serena Pierguidi, Antonella Nicosia, Valentina Picerno, Georgios Filippou, Luca Cantarini, Mauro Galeazzi
Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
Ramesh Boinpally, Harry Alcorn, Marijke H. Adams, James Longstreth, John Edwards
Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects
Jasper Dingemanse, Laurent Nicolas
Effect of Add-on Pentoxifylline on Proteinuria in Membranous Glomerulonephritis: A 6-month Placebo-controlled Trial
Shirinsadat Badri, Simin Dashti-Khavidaki, Farrokhlegha Ahmadi, Mitra Mahdavi-Mazdeh, Mohammad-Reza Abbasi, Hossein Khalili
17 α-Hydroxyprogesterone Caproate (Makena®)
Mary Hines, Katherine A. Lyseng-Williamson, Emma D. Deeks
Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
David Alexander Sclar, Linda M. Robison, Ambartsum M. Oganov, Jennifer M. Schmidt, Kurt A. Bowan, Leigh V. Castillo
Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL
Karl Henrik Johannes Ehinger, Magnus Joakim Hansson, Fredrik Sjövall, Eskil Elmér